Public-health topic
Published Research Radar records connected to the Vaccine safety topic through the auditable classification pipeline.
Evidence stream
30 of 377 publications shown
Eurosurveillance
Why it matters now The findings may inform future immunisation policy and public-health recommendations concerning co-administration of MVA-BN with other adult vaccines, particularly in adult men. The abstract describes this relevance as preliminary and exploratory.
The Lancet Infectious Diseases
Why it matters now Shigella is a leading cause of bacterial diarrhoea and dysentery worldwide, and no licensed vaccine currently exists. The trial results support further clinical development of live-attenuated shigella vaccines.
International Journal of Infectious Diseases
Why it matters now RZV produced strong antibody responses in PLWH irrespective of CD4 count, but cell-mediated responses were weaker than in HIV-negative people, informing vaccine expectation in this group.
Archives of public health = Archives belges de sante publique
Why it matters now The account underscores the difficulty of converting early warnings into rapid action and supports integrated preparedness planning for arboviral threats.
Vaccines
Why it matters now Dengue is a rapidly spreading arboviral disease; the review provides a strategic reference for safer and more effective next-generation vaccines.
Vaccine
Why it matters now The EPSS methodology provided near real-time, patient-reported safety data with denominator-based risk estimates, serving as a complement to routine pharmacovigilance for an intranasal paediatric influenza vaccine used in the UK programme.
Vaccine
Why it matters now The findings describe group-level perceptions surrounding COVID-19 vaccine safety, perceived rights violations, medical racism, and related misinformation. They may provide context for interpreting communication and opinion research about vaccination, but the abstract does not establish effects on vaccination behavior or population-level outcomes.
Philosophy, ethics, and humanities in medicine : PEHM
Why it matters now The article is relevant to vaccine safety review because it addresses how possible adverse events may be investigated when causality is uncertain. Its relevance is framed around COVID-19 vaccination, epistemic caution, and interpretation of anomalous safety findings.
Vaccine
Why it matters now The findings highlight missed opportunities among adults with prior or stated openness to vaccination and suggest strategies to improve coverage by reinforcing vaccine confidence, reducing access and logistical barriers, and facilitating vaccination completion.
Vaccine
Why it matters now Findings support counseling messages that same-day COVID-19 and influenza vaccination during pregnancy is generally well-tolerated, which may inform communication aimed at reducing vaccine hesitancy during seasonal overlap.
The Lancet Infectious Diseases
Why it matters now The abstract frames pertussis as an ongoing public health concern and describes BPZE1 as a candidate intended to induce mucosal immune responses. The reported findings support further development of this candidate in acellular pertussis vaccine-primed children aged 6 years and older.
Vaccine
Why it matters now Findings indicate MMR dose two is safe for children who had ITP after dose one, supporting continued vaccination practice.
Vaccine
Why it matters now Substantial caregiver hesitancy in early infancy, especially for COVID-19, suggests that improving vaccine knowledge may support adherence in this age group.
Vaccine
Why it matters now The abstract frames influenza as a major cause of morbidity in people living with HIV and notes that standard-dose vaccine responses are often suboptimal in this population.
Cureus
Why it matters now The study provides descriptive context on hepatitis reports submitted to a U.S. vaccine adverse-event reporting system and identifies differences in seriousness classification across age groups. The abstract does not support estimates of vaccine-specific risk or incidence, causal attribution, or a clinical or policy recommendation.
Frontiers in Cellular and Infection Microbiology
Why it matters now The paper addresses post-marketing vaccine safety surveillance for a routinely recommended vaccine. Its relevance is strongest for safety signal detection and hypothesis generation in Tdap vaccination programs.
International Journal of Infectious Diseases
Why it matters now Suboptimal vaccine uptake during pregnancy represents a continuing public health challenge. Clarifying evidence, addressing uncertainties, and identifying priorities may support improved maternal immunization programs.
Frontiers in Public Health
Why it matters now Identifying specific informational gaps and behavioral barriers supports the development of focused outreach initiatives. Aligning communication strategies with established community trust networks could enhance engagement with integrated disease management approaches.
Infectious Diseases of Poverty
Why it matters now The documented reporting patterns indicate a rationale for strengthening psychiatric symptom tracking during post-vaccination windows and refining safety communications within biodefense preparedness programs.
Vaccine
Why it matters now Continuous tracking of self-reported tolerability complements traditional clinical trial metrics and supports ongoing evaluation of emerging immunization products. Identifying engagement drop-offs informs strategy development for sustaining participant involvement during future public health emergencies.
npj Vaccines
Why it matters now The results support continued development of the vaccine candidate toward a human clinical trial, but the evidence does not establish human safety or efficacy.
Clinical Infectious Diseases
Why it matters now Findings indicate that concurrent RSV and COVID-19 mRNA vaccination in older adults is feasible with an acceptable safety profile, potentially simplifying seasonal immunization delivery.
The Lancet Infectious Diseases
Why it matters now Findings support further clinical assessment of the full-dose formulation without aluminium hydroxide in populations such as infants and older age groups in endemic regions, addressing the absence of licensed vaccines against Salmonella Paratyphi A.
npj Vaccines
Why it matters now The findings provide additional evidence from an endemic setting that the MVA-BN vaccine, widely deployed for monkeypox prevention, is generally safe and well-tolerated with predominantly mild injection site reactions.
The Lancet Infectious Diseases
Why it matters now The product is the first anti-PfCSP subunit vaccine with over 50% efficacy versus controlled challenge at 12 weeks, supporting further trials in young children against natural malaria.
The Lancet Infectious Diseases
Why it matters now The results support advancing PanChol to later-phase trials, including in endemic areas and children, as a potential single-dose alternative to multi-dose killed vaccines.
Vaccine
Why it matters now Findings support continued seasonal influenza vaccination in children by showing a consistent and non-alarming safety profile in VAERS during and around the pandemic.
Vaccine
Why it matters now Zoonotic H5N1 influenza may severely affect children; the study offers candidate pediatric vaccine data for pandemic preparedness.
Vaccine
Why it matters now Findings show RSV vaccine reactions are mostly transient and seldom need medical attention, supporting post-marketing safety monitoring using surveys and records.
Vaccine
Why it matters now Findings may help guide later refinement of RVFV vaccine safety assessment for pregnancy by indicating which animal model reveals placental tropism.
